Hallucinogens, serotonin and obsessive-compulsive disorder (Q34489965)

2 August 2017

1 reference

title

Hallucinogens, serotonin and obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

2 August 2017

0 references

0 references

author name string

Delgado PL

series ordinal

1

1 reference

PubMed ID

9924841

2 August 2017

Moreno FA

series ordinal

2

1 reference

2 August 2017

1 October 1998

1 reference

Journal of Psychoactive Drugs

2 August 2017

1 reference

2 August 2017

30

1 reference

2 August 2017

359-366

1 reference

2 August 2017

4

1 reference

The psychopharmacology of hallucinogens

2 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

LSD-like panic from risperidone in post-LSD visual disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

LSD treatment in a severe case of compulsive neurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Is there a relationship between clozapine and obsessive-compulsive disorder?: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Can clozapine trigger OCD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Psychedelic and entactogenic drugs in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1998.10399711

10.1080/02791072.1998.10399711

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

9924841